Filing Flows › Fennec Pharmaceuticals (FENC) › Q1 2026 › vs Q1 2025
Fennec Pharmaceuticals (FENC) Q1 2026 vs Q1 2025 (year over year)
Fennec Pharmaceuticals's revenue rose $6.4M (+73%) from $8.8M in Q1 2025 to $15.1M in Q1 2026.
Fennec Pharmaceuticals, Q1 2026: revenue $15.1M (+73% year over year), operating margin -0.8%, net earnings $201K, operating cash flow $2.4M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $15.1M | $8.8M | $6.4M | +73% |
| Other income, net | $320K | −$357K | $677K | — |
| Costs & expenses | $15.4M | $9.9M | $5.5M | +56% |
| Operating costs | $15.2M | $9.6M | $5.7M | +59% |
| Net earnings | $201K | −$1.2M | $1.4M | — |
| Research & development | $49K | $94K | −$45K | -48% |
| Sales & marketing | $11.4M | $3.2M | $8.2M | +254% |
| General & admin | $3.2M | $5.9M | −$2.7M | -46% |
| Other operating costs | $570K | $373K | $197K | +53% |
| Operating cash sources | $2.4M | −$4.3M | $6.7M | — |
| Share-based compensation | $990K | $798K | $192K | +24% |
| Working capital & other | $1.2M | −$4.0M | $5.1M | — |
| Operating cash flow | $2.4M | −$4.3M | $6.7M | — |
Questions
How much did Fennec Pharmaceuticals's revenue grow year over year in Q1 2026?
Fennec Pharmaceuticals's revenue rose $6.4M (+73%) from $8.8M in Q1 2025 to $15.1M in Q1 2026.